Biogen Inc

Common Name

Biogen

Country

United States

Sector

Healthcare

Industry

Drug Manufacturers - General

Employees

7,605

Ticker

BIIB

Exchange

NASDAQ/NGS

Website

www.biogen.com

Description

Biogen Inc. is a globally recognized biotechnology company committed to discovering, developing, and delivering innovative therapies for neurological diseases. With a focus on serious medical conditio... Show more

Financial Statements of Biogen

Below are the financial statements of Biogen, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in millions of USD	2024	2023
Current assets	—	—
Cash and cash equivalents	2,375^a	1,049.9^a
Accounts receivable, net	1,404.8^a	1,664.1^a
Due from anti-CD20 therapeutic programs	464^a	435.9^a
Inventory	2,460.5^a	2,527.4^a
Other current assets	752.5^a	1,182^a
Total current assets	7,456.8^a	6,859.3^a
Assets	—	—
Property, plant and equipment, net	3,181.3^a	3,309.7^a
Operating lease assets	356.4^a	420^a
Intangible assets, net	9,691.2^a	8,363^a
Goodwill	6,478.9^a	6,219.2^a
Deferred tax asset	324.2^a	928.6^a
Investments and other assets	560.5^a	745^a
Total assets	28,049.3^a	26,844.8^a
Current liabilities	—	—
Current portion of notes payable and term loan	1,748.6^a	150^a
Taxes payable	548.3^a	257.4^a
Accounts payable	424.2^a	403.3^a
Accrued expense and other	2,807.7^a	2,623.6^a
Total current liabilities	5,528.8^a	3,434.3^a
Liabilities and equity	—	—
Notes payable and term loan	4,547.2^a	6,788.2^a
Deferred tax liability	190.5^a	641.8^a
Long-term operating lease liabilities	334.5^a	400^a
Other long-term liabilities	732.3^a	781.1^a
Total liabilities	11,333.3^a	12,045.4^a
Equity: Biogen Inc. shareholders’ equity	—	—
Preferred stock	0^a	0^a
Common stock	0.1^a	0.1^a
Additional paid-in capital	569.4^a	302.5^a
Accumulated other comprehensive income (loss)	-136.2^a	-153.7^a
Retained earnings	19,259.8^a	17,627.6^a
Treasury stock, at cost	-2,977.1^a	-2,977.1^a
Total equity	16,716^a	14,799.4^a
Total liabilities and equity	28,049.3^a	26,844.8^a

Verified Sources Behind Biogen’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Biogen’s data sources below and access millions more through our Disclosure Search.

a. Biogen's Annual Report 2024

Trace every data point back to Biogen’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Biogen Inc

Financial Statements of Biogen

Verified Sources Behind Biogen’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Merck & Co Inc

Organon & Co

Gilead Sciences Inc

Quest Diagnostics Inc

Incyte Corp

Viatris Inc